nodes	percent_of_prediction	percent_of_DWPC	metapath
Lacosamide—L-Phenylalanine—Melphalan—peripheral nervous system neoplasm	0.579	1	CrCrCtD
Lacosamide—SCN3A—spinal nerve—peripheral nervous system neoplasm	0.0215	0.346	CbGeAlD
Lacosamide—SCN10A—nerve—peripheral nervous system neoplasm	0.00455	0.0731	CbGeAlD
Lacosamide—SCN10A—ganglion—peripheral nervous system neoplasm	0.00449	0.0722	CbGeAlD
Lacosamide—CA1—nerve—peripheral nervous system neoplasm	0.00377	0.0605	CbGeAlD
Lacosamide—CA6—parotid gland—peripheral nervous system neoplasm	0.00324	0.0521	CbGeAlD
Lacosamide—CA3—parotid gland—peripheral nervous system neoplasm	0.00307	0.0494	CbGeAlD
Lacosamide—CA4—nerve—peripheral nervous system neoplasm	0.00294	0.0473	CbGeAlD
Lacosamide—CA4—ganglion—peripheral nervous system neoplasm	0.00291	0.0467	CbGeAlD
Lacosamide—SCN9A—trigeminal ganglion—peripheral nervous system neoplasm	0.0029	0.0466	CbGeAlD
Lacosamide—L-Phenylalanine—TH—peripheral nervous system neoplasm	0.00263	1	CrCbGaD
Lacosamide—SCN10A—trigeminal ganglion—peripheral nervous system neoplasm	0.00221	0.0354	CbGeAlD
Lacosamide—CA9—cerebellum—peripheral nervous system neoplasm	0.00136	0.0219	CbGeAlD
Lacosamide—CA4—parotid gland—peripheral nervous system neoplasm	0.00135	0.0216	CbGeAlD
Lacosamide—CA14—cerebellum—peripheral nervous system neoplasm	0.00129	0.0207	CbGeAlD
Lacosamide—CA4—brainstem—peripheral nervous system neoplasm	0.00126	0.0203	CbGeAlD
Lacosamide—CA2—trigeminal ganglion—peripheral nervous system neoplasm	0.00118	0.019	CbGeAlD
Lacosamide—CA2—parotid gland—peripheral nervous system neoplasm	0.00112	0.0179	CbGeAlD
Lacosamide—CA2—brainstem—peripheral nervous system neoplasm	0.00105	0.0168	CbGeAlD
Lacosamide—SCN3A—cerebellum—peripheral nervous system neoplasm	0.000877	0.0141	CbGeAlD
Lacosamide—CA4—cerebellum—peripheral nervous system neoplasm	0.000623	0.01	CbGeAlD
Lacosamide—SCN9A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.0006	0.053	CbGpPWpGaD
Lacosamide—SCN3A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.000574	0.0507	CbGpPWpGaD
Lacosamide—SCN10A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.000532	0.047	CbGpPWpGaD
Lacosamide—CA2—cerebellum—peripheral nervous system neoplasm	0.000517	0.0083	CbGeAlD
Lacosamide—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.000501	0.00145	CcSEcCtD
Lacosamide—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.000499	0.00145	CcSEcCtD
Lacosamide—Anaemia—Cisplatin—peripheral nervous system neoplasm	0.000498	0.00144	CcSEcCtD
Lacosamide—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000495	0.00144	CcSEcCtD
Lacosamide—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000492	0.00143	CcSEcCtD
Lacosamide—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000488	0.00142	CcSEcCtD
Lacosamide—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000488	0.00142	CcSEcCtD
Lacosamide—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000487	0.00141	CcSEcCtD
Lacosamide—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000485	0.00141	CcSEcCtD
Lacosamide—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000482	0.0014	CcSEcCtD
Lacosamide—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000481	0.0014	CcSEcCtD
Lacosamide—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000481	0.0014	CcSEcCtD
Lacosamide—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.00048	0.00139	CcSEcCtD
Lacosamide—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.00048	0.00139	CcSEcCtD
Lacosamide—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000475	0.00138	CcSEcCtD
Lacosamide—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.000474	0.00138	CcSEcCtD
Lacosamide—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000469	0.00136	CcSEcCtD
Lacosamide—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000466	0.00135	CcSEcCtD
Lacosamide—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000466	0.00135	CcSEcCtD
Lacosamide—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000466	0.00135	CcSEcCtD
Lacosamide—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000463	0.00134	CcSEcCtD
Lacosamide—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00046	0.00133	CcSEcCtD
Lacosamide—Diplopia—Epirubicin—peripheral nervous system neoplasm	0.000459	0.00133	CcSEcCtD
Lacosamide—Osteoarthritis—Epirubicin—peripheral nervous system neoplasm	0.000459	0.00133	CcSEcCtD
Lacosamide—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000458	0.00133	CcSEcCtD
Lacosamide—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000458	0.00133	CcSEcCtD
Lacosamide—Anaemia—Etoposide—peripheral nervous system neoplasm	0.000456	0.00132	CcSEcCtD
Lacosamide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000455	0.00132	CcSEcCtD
Lacosamide—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000454	0.00132	CcSEcCtD
Lacosamide—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000454	0.00132	CcSEcCtD
Lacosamide—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000453	0.00131	CcSEcCtD
Lacosamide—Affect lability—Epirubicin—peripheral nervous system neoplasm	0.000452	0.00131	CcSEcCtD
Lacosamide—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00045	0.00131	CcSEcCtD
Lacosamide—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00045	0.00131	CcSEcCtD
Lacosamide—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000449	0.0013	CcSEcCtD
Lacosamide—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000446	0.00129	CcSEcCtD
Lacosamide—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000445	0.00129	CcSEcCtD
Lacosamide—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000445	0.00129	CcSEcCtD
Lacosamide—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000443	0.00129	CcSEcCtD
Lacosamide—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000441	0.00128	CcSEcCtD
Lacosamide—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.00044	0.00128	CcSEcCtD
Lacosamide—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000436	0.00127	CcSEcCtD
Lacosamide—Mood swings—Epirubicin—peripheral nervous system neoplasm	0.000435	0.00126	CcSEcCtD
Lacosamide—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000434	0.00126	CcSEcCtD
Lacosamide—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000433	0.00126	CcSEcCtD
Lacosamide—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000433	0.00126	CcSEcCtD
Lacosamide—Rash—Topotecan—peripheral nervous system neoplasm	0.000433	0.00125	CcSEcCtD
Lacosamide—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000432	0.00125	CcSEcCtD
Lacosamide—Ataxia—Epirubicin—peripheral nervous system neoplasm	0.000432	0.00125	CcSEcCtD
Lacosamide—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000431	0.00125	CcSEcCtD
Lacosamide—Headache—Topotecan—peripheral nervous system neoplasm	0.00043	0.00125	CcSEcCtD
Lacosamide—Rash—Tretinoin—peripheral nervous system neoplasm	0.000429	0.00124	CcSEcCtD
Lacosamide—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000429	0.00124	CcSEcCtD
Lacosamide—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000429	0.00124	CcSEcCtD
Lacosamide—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000429	0.00124	CcSEcCtD
Lacosamide—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000429	0.00124	CcSEcCtD
Lacosamide—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000428	0.00124	CcSEcCtD
Lacosamide—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000427	0.00124	CcSEcCtD
Lacosamide—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000427	0.00124	CcSEcCtD
Lacosamide—Headache—Tretinoin—peripheral nervous system neoplasm	0.000426	0.00124	CcSEcCtD
Lacosamide—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000426	0.00124	CcSEcCtD
Lacosamide—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000425	0.00123	CcSEcCtD
Lacosamide—Constipation—Vincristine—peripheral nervous system neoplasm	0.000425	0.00123	CcSEcCtD
Lacosamide—Osteoarthritis—Doxorubicin—peripheral nervous system neoplasm	0.000425	0.00123	CcSEcCtD
Lacosamide—Diplopia—Doxorubicin—peripheral nervous system neoplasm	0.000425	0.00123	CcSEcCtD
Lacosamide—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000425	0.00123	CcSEcCtD
Lacosamide—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.000424	0.00123	CcSEcCtD
Lacosamide—Rash—Melphalan—peripheral nervous system neoplasm	0.000423	0.00123	CcSEcCtD
Lacosamide—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000423	0.00123	CcSEcCtD
Lacosamide—Chest pain—Etoposide—peripheral nervous system neoplasm	0.00042	0.00122	CcSEcCtD
Lacosamide—Affect lability—Doxorubicin—peripheral nervous system neoplasm	0.000418	0.00121	CcSEcCtD
Lacosamide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000417	0.00121	CcSEcCtD
Lacosamide—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000415	0.0012	CcSEcCtD
Lacosamide—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.000413	0.0012	CcSEcCtD
Lacosamide—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00041	0.00119	CcSEcCtD
Lacosamide—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.00041	0.00119	CcSEcCtD
Lacosamide—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000408	0.00118	CcSEcCtD
Lacosamide—Nausea—Topotecan—peripheral nervous system neoplasm	0.000407	0.00118	CcSEcCtD
Lacosamide—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000406	0.00118	CcSEcCtD
Lacosamide—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000404	0.00117	CcSEcCtD
Lacosamide—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000404	0.00117	CcSEcCtD
Lacosamide—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.000402	0.00117	CcSEcCtD
Lacosamide—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.000399	0.00116	CcSEcCtD
Lacosamide—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000399	0.00116	CcSEcCtD
Lacosamide—Nausea—Melphalan—peripheral nervous system neoplasm	0.000399	0.00116	CcSEcCtD
Lacosamide—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000395	0.00114	CcSEcCtD
Lacosamide—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000393	0.00114	CcSEcCtD
Lacosamide—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000393	0.00114	CcSEcCtD
Lacosamide—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000392	0.00114	CcSEcCtD
Lacosamide—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000391	0.00113	CcSEcCtD
Lacosamide—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000389	0.00113	CcSEcCtD
Lacosamide—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.000383	0.00111	CcSEcCtD
Lacosamide—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000381	0.0011	CcSEcCtD
Lacosamide—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00038	0.0011	CcSEcCtD
Lacosamide—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000379	0.0011	CcSEcCtD
Lacosamide—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000371	0.00108	CcSEcCtD
Lacosamide—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00037	0.00107	CcSEcCtD
Lacosamide—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000366	0.00106	CcSEcCtD
Lacosamide—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000365	0.00106	CcSEcCtD
Lacosamide—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000364	0.00105	CcSEcCtD
Lacosamide—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000362	0.00105	CcSEcCtD
Lacosamide—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000361	0.00105	CcSEcCtD
Lacosamide—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000358	0.00104	CcSEcCtD
Lacosamide—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000357	0.00103	CcSEcCtD
Lacosamide—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000354	0.00103	CcSEcCtD
Lacosamide—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000353	0.00102	CcSEcCtD
Lacosamide—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000351	0.00102	CcSEcCtD
Lacosamide—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000351	0.00102	CcSEcCtD
Lacosamide—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000348	0.00101	CcSEcCtD
Lacosamide—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000347	0.00101	CcSEcCtD
Lacosamide—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000347	0.00101	CcSEcCtD
Lacosamide—Constipation—Etoposide—peripheral nervous system neoplasm	0.000344	0.000999	CcSEcCtD
Lacosamide—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000343	0.000996	CcSEcCtD
Lacosamide—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000341	0.00099	CcSEcCtD
Lacosamide—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00034	0.000987	CcSEcCtD
Lacosamide—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000335	0.000971	CcSEcCtD
Lacosamide—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000332	0.000963	CcSEcCtD
Lacosamide—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00033	0.000959	CcSEcCtD
Lacosamide—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.00033	0.000958	CcSEcCtD
Lacosamide—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000329	0.000953	CcSEcCtD
Lacosamide—CA1—C-MYB transcription factor network—CD34—peripheral nervous system neoplasm	0.000329	0.029	CbGpPWpGaD
Lacosamide—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000328	0.000951	CcSEcCtD
Lacosamide—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000325	0.000943	CcSEcCtD
Lacosamide—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000325	0.000943	CcSEcCtD
Lacosamide—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000325	0.000942	CcSEcCtD
Lacosamide—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000324	0.000939	CcSEcCtD
Lacosamide—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000323	0.000938	CcSEcCtD
Lacosamide—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000323	0.000937	CcSEcCtD
Lacosamide—Urticaria—Etoposide—peripheral nervous system neoplasm	0.00032	0.000928	CcSEcCtD
Lacosamide—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000318	0.000923	CcSEcCtD
Lacosamide—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000318	0.000922	CcSEcCtD
Lacosamide—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000316	0.000917	CcSEcCtD
Lacosamide—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000316	0.000917	CcSEcCtD
Lacosamide—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000315	0.000915	CcSEcCtD
Lacosamide—Rash—Vincristine—peripheral nervous system neoplasm	0.000313	0.000909	CcSEcCtD
Lacosamide—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000313	0.000908	CcSEcCtD
Lacosamide—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000312	0.000906	CcSEcCtD
Lacosamide—Headache—Vincristine—peripheral nervous system neoplasm	0.000311	0.000903	CcSEcCtD
Lacosamide—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.00031	0.000898	CcSEcCtD
Lacosamide—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000306	0.000889	CcSEcCtD
Lacosamide—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000305	0.000886	CcSEcCtD
Lacosamide—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000301	0.000872	CcSEcCtD
Lacosamide—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.0003	0.000871	CcSEcCtD
Lacosamide—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000299	0.000868	CcSEcCtD
Lacosamide—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000297	0.000861	CcSEcCtD
Lacosamide—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000297	0.000861	CcSEcCtD
Lacosamide—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000296	0.000859	CcSEcCtD
Lacosamide—Nausea—Vincristine—peripheral nervous system neoplasm	0.000295	0.000856	CcSEcCtD
Lacosamide—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000295	0.000855	CcSEcCtD
Lacosamide—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000294	0.000853	CcSEcCtD
Lacosamide—SCN9A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.000293	0.0259	CbGpPWpGaD
Lacosamide—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000292	0.000848	CcSEcCtD
Lacosamide—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000289	0.000838	CcSEcCtD
Lacosamide—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000289	0.000838	CcSEcCtD
Lacosamide—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000287	0.000832	CcSEcCtD
Lacosamide—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000285	0.000826	CcSEcCtD
Lacosamide—SCN3A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.00028	0.0248	CbGpPWpGaD
Lacosamide—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000279	0.000811	CcSEcCtD
Lacosamide—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000278	0.000807	CcSEcCtD
Lacosamide—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000278	0.000806	CcSEcCtD
Lacosamide—Rash—Cisplatin—peripheral nervous system neoplasm	0.000277	0.000804	CcSEcCtD
Lacosamide—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000277	0.000803	CcSEcCtD
Lacosamide—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000276	0.000802	CcSEcCtD
Lacosamide—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000275	0.000799	CcSEcCtD
Lacosamide—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000275	0.000797	CcSEcCtD
Lacosamide—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000274	0.000795	CcSEcCtD
Lacosamide—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000273	0.000791	CcSEcCtD
Lacosamide—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000272	0.000791	CcSEcCtD
Lacosamide—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000266	0.000772	CcSEcCtD
Lacosamide—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000266	0.000771	CcSEcCtD
Lacosamide—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000265	0.00077	CcSEcCtD
Lacosamide—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000261	0.000757	CcSEcCtD
Lacosamide—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000261	0.000756	CcSEcCtD
Lacosamide—SCN10A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.00026	0.0229	CbGpPWpGaD
Lacosamide—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000257	0.000747	CcSEcCtD
Lacosamide—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000256	0.000743	CcSEcCtD
Lacosamide—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000256	0.000742	CcSEcCtD
Lacosamide—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000256	0.000741	CcSEcCtD
Lacosamide—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000254	0.000737	CcSEcCtD
Lacosamide—Rash—Etoposide—peripheral nervous system neoplasm	0.000254	0.000736	CcSEcCtD
Lacosamide—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000254	0.000736	CcSEcCtD
Lacosamide—Headache—Etoposide—peripheral nervous system neoplasm	0.000252	0.000732	CcSEcCtD
Lacosamide—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000252	0.000731	CcSEcCtD
Lacosamide—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000248	0.000721	CcSEcCtD
Lacosamide—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000248	0.000719	CcSEcCtD
Lacosamide—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000246	0.000714	CcSEcCtD
Lacosamide—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000244	0.000709	CcSEcCtD
Lacosamide—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000243	0.000705	CcSEcCtD
Lacosamide—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000241	0.0007	CcSEcCtD
Lacosamide—Nausea—Etoposide—peripheral nervous system neoplasm	0.000239	0.000694	CcSEcCtD
Lacosamide—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000236	0.000686	CcSEcCtD
Lacosamide—CA9—HIF-1-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	0.000235	0.0208	CbGpPWpGaD
Lacosamide—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000235	0.000683	CcSEcCtD
Lacosamide—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000235	0.000682	CcSEcCtD
Lacosamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000234	0.000678	CcSEcCtD
Lacosamide—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000233	0.000675	CcSEcCtD
Lacosamide—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.00023	0.000668	CcSEcCtD
Lacosamide—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.00023	0.000667	CcSEcCtD
Lacosamide—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000229	0.000666	CcSEcCtD
Lacosamide—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000228	0.00066	CcSEcCtD
Lacosamide—SCN9A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.000227	0.02	CbGpPWpGaD
Lacosamide—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.000656	CcSEcCtD
Lacosamide—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000225	0.000652	CcSEcCtD
Lacosamide—CA3—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000224	0.0198	CbGpPWpGaD
Lacosamide—Shock—Epirubicin—peripheral nervous system neoplasm	0.000222	0.000644	CcSEcCtD
Lacosamide—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000221	0.000642	CcSEcCtD
Lacosamide—CA9—Cellular responses to stress—EED—peripheral nervous system neoplasm	0.00022	0.0194	CbGpPWpGaD
Lacosamide—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000219	0.000636	CcSEcCtD
Lacosamide—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000218	0.000633	CcSEcCtD
Lacosamide—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000218	0.000632	CcSEcCtD
Lacosamide—SCN3A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.000217	0.0192	CbGpPWpGaD
Lacosamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000216	0.000628	CcSEcCtD
Lacosamide—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000215	0.000624	CcSEcCtD
Lacosamide—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000213	0.000618	CcSEcCtD
Lacosamide—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000211	0.000611	CcSEcCtD
Lacosamide—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000205	0.000596	CcSEcCtD
Lacosamide—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000205	0.000594	CcSEcCtD
Lacosamide—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000204	0.000592	CcSEcCtD
Lacosamide—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000203	0.000588	CcSEcCtD
Lacosamide—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000203	0.000588	CcSEcCtD
Lacosamide—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000202	0.000586	CcSEcCtD
Lacosamide—SCN10A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.000201	0.0178	CbGpPWpGaD
Lacosamide—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000201	0.000582	CcSEcCtD
Lacosamide—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000199	0.000576	CcSEcCtD
Lacosamide—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000195	0.000565	CcSEcCtD
Lacosamide—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000195	0.000564	CcSEcCtD
Lacosamide—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000193	0.00056	CcSEcCtD
Lacosamide—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000189	0.000548	CcSEcCtD
Lacosamide—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.000544	CcSEcCtD
Lacosamide—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000186	0.00054	CcSEcCtD
Lacosamide—CA9—HIF-1-alpha transcription factor network—ABCB1—peripheral nervous system neoplasm	0.000186	0.0164	CbGpPWpGaD
Lacosamide—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.000539	CcSEcCtD
Lacosamide—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000184	0.000533	CcSEcCtD
Lacosamide—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.00018	0.000523	CcSEcCtD
Lacosamide—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.00018	0.000522	CcSEcCtD
Lacosamide—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000179	0.00052	CcSEcCtD
Lacosamide—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.000518	CcSEcCtD
Lacosamide—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000178	0.000518	CcSEcCtD
Lacosamide—CA9—Cellular responses to stress—SUZ12—peripheral nervous system neoplasm	0.000176	0.0155	CbGpPWpGaD
Lacosamide—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.000499	CcSEcCtD
Lacosamide—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000166	0.000482	CcSEcCtD
Lacosamide—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.000481	CcSEcCtD
Lacosamide—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.000479	CcSEcCtD
Lacosamide—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000162	0.00047	CcSEcCtD
Lacosamide—SCN9A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.000162	0.0143	CbGpPWpGaD
Lacosamide—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000463	CcSEcCtD
Lacosamide—SCN3A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.000155	0.0137	CbGpPWpGaD
Lacosamide—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000154	0.000448	CcSEcCtD
Lacosamide—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.000446	CcSEcCtD
Lacosamide—CA3—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000151	0.0134	CbGpPWpGaD
Lacosamide—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000435	CcSEcCtD
Lacosamide—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000433	CcSEcCtD
Lacosamide—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000429	CcSEcCtD
Lacosamide—CA14—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000144	0.0128	CbGpPWpGaD
Lacosamide—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000143	0.000416	CcSEcCtD
Lacosamide—SCN10A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.000143	0.0127	CbGpPWpGaD
Lacosamide—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000415	CcSEcCtD
Lacosamide—Rash—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000413	CcSEcCtD
Lacosamide—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000412	CcSEcCtD
Lacosamide—Headache—Epirubicin—peripheral nervous system neoplasm	0.000141	0.00041	CcSEcCtD
Lacosamide—CA6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000141	0.0124	CbGpPWpGaD
Lacosamide—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000401	CcSEcCtD
Lacosamide—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000389	CcSEcCtD
Lacosamide—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000385	CcSEcCtD
Lacosamide—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000382	CcSEcCtD
Lacosamide—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000382	CcSEcCtD
Lacosamide—CA5B—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000131	0.0116	CbGpPWpGaD
Lacosamide—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.00038	CcSEcCtD
Lacosamide—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.00036	CcSEcCtD
Lacosamide—SCN9A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000111	0.00979	CbGpPWpGaD
Lacosamide—CA3—Metabolism—GNS—peripheral nervous system neoplasm	0.000109	0.00968	CbGpPWpGaD
Lacosamide—SCN3A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000106	0.00936	CbGpPWpGaD
Lacosamide—CA3—Metabolism—NME1—peripheral nervous system neoplasm	0.000105	0.00928	CbGpPWpGaD
Lacosamide—CA1—C-MYB transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.000102	0.00902	CbGpPWpGaD
Lacosamide—CA3—Metabolism—COX2—peripheral nervous system neoplasm	0.000101	0.00893	CbGpPWpGaD
Lacosamide—SCN10A—Axon guidance—NCAM1—peripheral nervous system neoplasm	9.81e-05	0.00867	CbGpPWpGaD
Lacosamide—CA14—Metabolism—HSD17B12—peripheral nervous system neoplasm	9.76e-05	0.00863	CbGpPWpGaD
Lacosamide—CA4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	9.71e-05	0.00858	CbGpPWpGaD
Lacosamide—CA6—Metabolism—HSD17B12—peripheral nervous system neoplasm	9.51e-05	0.00841	CbGpPWpGaD
Lacosamide—CA2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	9.31e-05	0.00823	CbGpPWpGaD
Lacosamide—CA1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	8.93e-05	0.00789	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—HSD17B12—peripheral nervous system neoplasm	8.88e-05	0.00785	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	7.9e-05	0.00698	CbGpPWpGaD
Lacosamide—CA9—Metabolism—PPIP5K2—peripheral nervous system neoplasm	7.85e-05	0.00694	CbGpPWpGaD
Lacosamide—CA9—Cellular responses to stress—IFNB1—peripheral nervous system neoplasm	7.71e-05	0.00682	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	7.56e-05	0.00668	CbGpPWpGaD
Lacosamide—CA1—C-MYB transcription factor network—NRAS—peripheral nervous system neoplasm	7.42e-05	0.00656	CbGpPWpGaD
Lacosamide—CA14—Metabolism—GNS—peripheral nervous system neoplasm	7.06e-05	0.00624	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	7e-05	0.00619	CbGpPWpGaD
Lacosamide—CA1—C-MYB transcription factor network—MYC—peripheral nervous system neoplasm	6.92e-05	0.00611	CbGpPWpGaD
Lacosamide—CA6—Metabolism—GNS—peripheral nervous system neoplasm	6.88e-05	0.00608	CbGpPWpGaD
Lacosamide—CA14—Metabolism—NME1—peripheral nervous system neoplasm	6.76e-05	0.00598	CbGpPWpGaD
Lacosamide—CA3—Metabolism—ENO2—peripheral nervous system neoplasm	6.63e-05	0.00586	CbGpPWpGaD
Lacosamide—CA6—Metabolism—NME1—peripheral nervous system neoplasm	6.59e-05	0.00583	CbGpPWpGaD
Lacosamide—CA4—Metabolism—HSD17B12—peripheral nervous system neoplasm	6.56e-05	0.0058	CbGpPWpGaD
Lacosamide—CA14—Metabolism—COX2—peripheral nervous system neoplasm	6.51e-05	0.00576	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—GNS—peripheral nervous system neoplasm	6.42e-05	0.00567	CbGpPWpGaD
Lacosamide—CA6—Metabolism—COX2—peripheral nervous system neoplasm	6.35e-05	0.00561	CbGpPWpGaD
Lacosamide—CA2—Metabolism—HSD17B12—peripheral nervous system neoplasm	6.29e-05	0.00556	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—NME1—peripheral nervous system neoplasm	6.15e-05	0.00544	CbGpPWpGaD
Lacosamide—CA1—Metabolism—HSD17B12—peripheral nervous system neoplasm	6.03e-05	0.00533	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—COX2—peripheral nervous system neoplasm	5.92e-05	0.00524	CbGpPWpGaD
Lacosamide—CA3—Metabolism—BCHE—peripheral nervous system neoplasm	5.6e-05	0.00495	CbGpPWpGaD
Lacosamide—CA1—C-MYB transcription factor network—HRAS—peripheral nervous system neoplasm	5.43e-05	0.0048	CbGpPWpGaD
Lacosamide—CA3—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.35e-05	0.00473	CbGpPWpGaD
Lacosamide—CA9—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.3e-05	0.00469	CbGpPWpGaD
Lacosamide—SCN9A—Axon guidance—MET—peripheral nervous system neoplasm	5.29e-05	0.00468	CbGpPWpGaD
Lacosamide—CA3—Metabolism—TH—peripheral nervous system neoplasm	5.27e-05	0.00466	CbGpPWpGaD
Lacosamide—CA9—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	5.11e-05	0.00452	CbGpPWpGaD
Lacosamide—SCN3A—Axon guidance—MET—peripheral nervous system neoplasm	5.06e-05	0.00447	CbGpPWpGaD
Lacosamide—SCN9A—Axon guidance—PTPN11—peripheral nervous system neoplasm	4.89e-05	0.00433	CbGpPWpGaD
Lacosamide—CA4—Metabolism—GNS—peripheral nervous system neoplasm	4.74e-05	0.00419	CbGpPWpGaD
Lacosamide—SCN10A—Axon guidance—MET—peripheral nervous system neoplasm	4.69e-05	0.00414	CbGpPWpGaD
Lacosamide—SCN3A—Axon guidance—PTPN11—peripheral nervous system neoplasm	4.68e-05	0.00414	CbGpPWpGaD
Lacosamide—CA4—Metabolism—NME1—peripheral nervous system neoplasm	4.55e-05	0.00402	CbGpPWpGaD
Lacosamide—CA2—Metabolism—GNS—peripheral nervous system neoplasm	4.55e-05	0.00402	CbGpPWpGaD
Lacosamide—CA4—Metabolism—COX2—peripheral nervous system neoplasm	4.38e-05	0.00387	CbGpPWpGaD
Lacosamide—CA1—Metabolism—GNS—peripheral nervous system neoplasm	4.36e-05	0.00385	CbGpPWpGaD
Lacosamide—CA2—Metabolism—NME1—peripheral nervous system neoplasm	4.36e-05	0.00385	CbGpPWpGaD
Lacosamide—SCN10A—Axon guidance—PTPN11—peripheral nervous system neoplasm	4.34e-05	0.00383	CbGpPWpGaD
Lacosamide—CA3—Metabolism—GNAS—peripheral nervous system neoplasm	4.3e-05	0.0038	CbGpPWpGaD
Lacosamide—CA14—Metabolism—ENO2—peripheral nervous system neoplasm	4.27e-05	0.00378	CbGpPWpGaD
Lacosamide—CA3—Metabolism—ABCB1—peripheral nervous system neoplasm	4.22e-05	0.00373	CbGpPWpGaD
Lacosamide—CA2—Metabolism—COX2—peripheral nervous system neoplasm	4.2e-05	0.00371	CbGpPWpGaD
Lacosamide—CA1—Metabolism—NME1—peripheral nervous system neoplasm	4.18e-05	0.00369	CbGpPWpGaD
Lacosamide—CA6—Metabolism—ENO2—peripheral nervous system neoplasm	4.17e-05	0.00368	CbGpPWpGaD
Lacosamide—CA1—Metabolism—COX2—peripheral nervous system neoplasm	4.02e-05	0.00356	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—ENO2—peripheral nervous system neoplasm	3.89e-05	0.00344	CbGpPWpGaD
Lacosamide—SCN9A—Axon guidance—ERBB2—peripheral nervous system neoplasm	3.87e-05	0.00342	CbGpPWpGaD
Lacosamide—CA9—Metabolism—GNS—peripheral nervous system neoplasm	3.83e-05	0.00339	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—MET—peripheral nervous system neoplasm	3.78e-05	0.00334	CbGpPWpGaD
Lacosamide—SCN3A—Axon guidance—ERBB2—peripheral nervous system neoplasm	3.7e-05	0.00327	CbGpPWpGaD
Lacosamide—CA9—Metabolism—NME1—peripheral nervous system neoplasm	3.67e-05	0.00325	CbGpPWpGaD
Lacosamide—CA14—Metabolism—BCHE—peripheral nervous system neoplasm	3.61e-05	0.00319	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—MET—peripheral nervous system neoplasm	3.61e-05	0.00319	CbGpPWpGaD
Lacosamide—CA9—Cellular responses to stress—CDKN2A—peripheral nervous system neoplasm	3.59e-05	0.00317	CbGpPWpGaD
Lacosamide—CA9—Metabolism—COX2—peripheral nervous system neoplasm	3.54e-05	0.00313	CbGpPWpGaD
Lacosamide—CA6—Metabolism—BCHE—peripheral nervous system neoplasm	3.52e-05	0.00311	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	3.49e-05	0.00309	CbGpPWpGaD
Lacosamide—CA14—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.45e-05	0.00305	CbGpPWpGaD
Lacosamide—SCN10A—Axon guidance—ERBB2—peripheral nervous system neoplasm	3.43e-05	0.00303	CbGpPWpGaD
Lacosamide—CA14—Metabolism—TH—peripheral nervous system neoplasm	3.4e-05	0.003	CbGpPWpGaD
Lacosamide—CA6—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.36e-05	0.00297	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—MET—peripheral nervous system neoplasm	3.35e-05	0.00296	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	3.34e-05	0.00295	CbGpPWpGaD
Lacosamide—CA6—Metabolism—TH—peripheral nervous system neoplasm	3.31e-05	0.00293	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—BCHE—peripheral nervous system neoplasm	3.29e-05	0.0029	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.13e-05	0.00277	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	3.09e-05	0.00274	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—TH—peripheral nervous system neoplasm	3.09e-05	0.00273	CbGpPWpGaD
Lacosamide—SCN9A—Axon guidance—NRAS—peripheral nervous system neoplasm	2.94e-05	0.0026	CbGpPWpGaD
Lacosamide—CA4—Metabolism—ENO2—peripheral nervous system neoplasm	2.87e-05	0.00254	CbGpPWpGaD
Lacosamide—SCN3A—Axon guidance—NRAS—peripheral nervous system neoplasm	2.81e-05	0.00249	CbGpPWpGaD
Lacosamide—CA14—Metabolism—GNAS—peripheral nervous system neoplasm	2.77e-05	0.00245	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	2.76e-05	0.00244	CbGpPWpGaD
Lacosamide—CA2—Metabolism—ENO2—peripheral nervous system neoplasm	2.75e-05	0.00243	CbGpPWpGaD
Lacosamide—CA14—Metabolism—ABCB1—peripheral nervous system neoplasm	2.72e-05	0.0024	CbGpPWpGaD
Lacosamide—CA6—Metabolism—GNAS—peripheral nervous system neoplasm	2.7e-05	0.00239	CbGpPWpGaD
Lacosamide—CA6—Metabolism—ABCB1—peripheral nervous system neoplasm	2.65e-05	0.00234	CbGpPWpGaD
Lacosamide—CA1—Metabolism—ENO2—peripheral nervous system neoplasm	2.64e-05	0.00233	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	2.64e-05	0.00233	CbGpPWpGaD
Lacosamide—SCN10A—Axon guidance—NRAS—peripheral nervous system neoplasm	2.61e-05	0.0023	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—GNAS—peripheral nervous system neoplasm	2.52e-05	0.00223	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—ABCB1—peripheral nervous system neoplasm	2.47e-05	0.00219	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	2.45e-05	0.00216	CbGpPWpGaD
Lacosamide—CA4—Metabolism—BCHE—peripheral nervous system neoplasm	2.43e-05	0.00215	CbGpPWpGaD
Lacosamide—CA2—Metabolism—BCHE—peripheral nervous system neoplasm	2.33e-05	0.00206	CbGpPWpGaD
Lacosamide—CA9—Metabolism—ENO2—peripheral nervous system neoplasm	2.32e-05	0.00205	CbGpPWpGaD
Lacosamide—CA4—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.32e-05	0.00205	CbGpPWpGaD
Lacosamide—CA4—Metabolism—TH—peripheral nervous system neoplasm	2.28e-05	0.00202	CbGpPWpGaD
Lacosamide—CA1—Metabolism—BCHE—peripheral nervous system neoplasm	2.23e-05	0.00197	CbGpPWpGaD
Lacosamide—CA2—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.22e-05	0.00196	CbGpPWpGaD
Lacosamide—CA2—Metabolism—TH—peripheral nervous system neoplasm	2.19e-05	0.00193	CbGpPWpGaD
Lacosamide—SCN9A—Axon guidance—HRAS—peripheral nervous system neoplasm	2.15e-05	0.0019	CbGpPWpGaD
Lacosamide—CA1—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.13e-05	0.00188	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—NRAS—peripheral nervous system neoplasm	2.1e-05	0.00186	CbGpPWpGaD
Lacosamide—CA1—Metabolism—TH—peripheral nervous system neoplasm	2.1e-05	0.00185	CbGpPWpGaD
Lacosamide—SCN3A—Axon guidance—HRAS—peripheral nervous system neoplasm	2.06e-05	0.00182	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—NRAS—peripheral nervous system neoplasm	2.01e-05	0.00178	CbGpPWpGaD
Lacosamide—CA9—Cellular responses to stress—TP53—peripheral nervous system neoplasm	2e-05	0.00177	CbGpPWpGaD
Lacosamide—CA9—Metabolism—BCHE—peripheral nervous system neoplasm	1.96e-05	0.00173	CbGpPWpGaD
Lacosamide—SCN10A—Axon guidance—HRAS—peripheral nervous system neoplasm	1.91e-05	0.00169	CbGpPWpGaD
Lacosamide—CA9—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.87e-05	0.00165	CbGpPWpGaD
Lacosamide—CA4—Metabolism—GNAS—peripheral nervous system neoplasm	1.86e-05	0.00165	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—NRAS—peripheral nervous system neoplasm	1.86e-05	0.00164	CbGpPWpGaD
Lacosamide—CA9—Metabolism—TH—peripheral nervous system neoplasm	1.84e-05	0.00163	CbGpPWpGaD
Lacosamide—CA4—Metabolism—ABCB1—peripheral nervous system neoplasm	1.83e-05	0.00162	CbGpPWpGaD
Lacosamide—CA2—Metabolism—GNAS—peripheral nervous system neoplasm	1.79e-05	0.00158	CbGpPWpGaD
Lacosamide—CA2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.75e-05	0.00155	CbGpPWpGaD
Lacosamide—CA1—Metabolism—GNAS—peripheral nervous system neoplasm	1.71e-05	0.00151	CbGpPWpGaD
Lacosamide—CA1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.68e-05	0.00149	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—HRAS—peripheral nervous system neoplasm	1.54e-05	0.00136	CbGpPWpGaD
Lacosamide—CA9—Metabolism—GNAS—peripheral nervous system neoplasm	1.51e-05	0.00133	CbGpPWpGaD
Lacosamide—CA9—Metabolism—ABCB1—peripheral nervous system neoplasm	1.48e-05	0.00131	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—HRAS—peripheral nervous system neoplasm	1.47e-05	0.0013	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—HRAS—peripheral nervous system neoplasm	1.36e-05	0.0012	CbGpPWpGaD
Lacosamide—SCN9A—Developmental Biology—AKT1—peripheral nervous system neoplasm	1.36e-05	0.0012	CbGpPWpGaD
Lacosamide—SCN3A—Developmental Biology—AKT1—peripheral nervous system neoplasm	1.3e-05	0.00115	CbGpPWpGaD
Lacosamide—SCN10A—Developmental Biology—AKT1—peripheral nervous system neoplasm	1.2e-05	0.00106	CbGpPWpGaD
Lacosamide—CA3—Metabolism—AKT1—peripheral nervous system neoplasm	1.16e-05	0.00103	CbGpPWpGaD
Lacosamide—CA14—Metabolism—AKT1—peripheral nervous system neoplasm	7.48e-06	0.000661	CbGpPWpGaD
Lacosamide—CA6—Metabolism—AKT1—peripheral nervous system neoplasm	7.29e-06	0.000645	CbGpPWpGaD
Lacosamide—CA5B—Metabolism—AKT1—peripheral nervous system neoplasm	6.81e-06	0.000602	CbGpPWpGaD
Lacosamide—CA4—Metabolism—AKT1—peripheral nervous system neoplasm	5.03e-06	0.000445	CbGpPWpGaD
Lacosamide—CA2—Metabolism—AKT1—peripheral nervous system neoplasm	4.82e-06	0.000426	CbGpPWpGaD
Lacosamide—CA1—Metabolism—AKT1—peripheral nervous system neoplasm	4.62e-06	0.000409	CbGpPWpGaD
Lacosamide—CA9—Metabolism—AKT1—peripheral nervous system neoplasm	4.06e-06	0.000359	CbGpPWpGaD
